CRP and temporal arteritis: Non-significant trends of favoring biologic therapies in reducing CRP level for GCA and relapse rate, ITAS-2010, ITAS-A, ESR, and CRP in TAK and increasing remission rate and relapse-free survival for TAK were also observed.